AH Bio Fund II, L.P.

10% Owner · 2 filings · Latest: Jul 27, 2026

Nautilus Biotechnology, Inc.

Scribe Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SCTX	AH Bio Fund II, L.P.	10% Owner	Jul 27, 2026	Purchase	$15.00	333,333	$5.0M	2,385,075	Jul 29 11:09 PM
NAUT	AH Bio Fund II, L.P.	10% Owner	Jun 2, 2026	Sale	$2.35	5,000,000	$11.8M	971,885	Jun 4 8:53 PM